PolyPid is an Israel-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of inflammation and cancer.
Business Model:
Revenue: $0
Employees: 51-200
Address: 18 Hasivim Street
City: Petach Tikva
State: center district
Zip: 4917002
Country: IL
PolyPid is an Israel-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of inflammation and cancer.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
6/30/2020
Ticker Symbol:
PYPD
IPO Price:
$16/share
Amount Raised:
$69M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2020 | Venture Round | $69M | 6/2014 | Series B | $10.9M | 6/2019 | Equity | $26.9M | 2/2016 | Series D | $0 |
Shavit Capital Chaim Hurvitz Shavit Capital Shavit Capital Chaim Hurvitz Shavit Capital |
9/2019 | Series E | $50M | 12/2011 | Series A | $2.2M | 11/2018 | Equity | $15M |
Kreos Capital Xenia Venture Capital |
6/2020 | IPO | $61.1M |
|
6/2020 | Funding Round | $69M | 10/2018 | Series E | $65.3M | 11/2015 | Series C | 2 | $8.3M |
Financiere Saint James GUIBOR Financiere Saint James GUIBOR |
4/2022 | Post-IPO Debt | 1 | $15M |
Kreos Capital VI Kreos Capital |
2/2016 | Series D | 2 | $27.3M |
Shavit Capital Chaim Hurvitz Shavit Capital Shavit Capital Chaim Hurvitz Shavit Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|